All Stories

  1. Trends in Helicobacter pylori prevalence, force of infection, and attributable disease burden in China: a systematic review and Bayesian modelling study

    Article • The Lancet Regional Health - Western Pacific, September 2026, Elsevier

    Dr Fernando Alarid-Escudero

  2. Trial-based Cost-effectiveness Analysis of Descemet Endothelial Thickness Comparison Trial Therapeutic Exploratory Study, A Randomized Trial Comparing Ultrathin Descemet Stripping Automated Endothelial Keratoplasty With Descemet Membrane Endothelial Ke...

    Article • Cornea, August 2026, Wolters Kluwer Health

    Dr Fernando Alarid-Escudero

  3. Cost-effectiveness of fecal immunochemical testing for colorectal cancer in Mexico City: A microsimulation modeling study

    Article • Journal of Medical Screening, May 2026, SAGE Publications

    Dr Fernando Alarid-Escudero

  4. A Tutorial on Discrete Event Simulation Models Using a Cost-Effectiveness Analysis Example in R

    Article • Medical Decision Making, May 2026, SAGE Publications

    Dr Fernando Alarid-Escudero

  5. A Microsimulation-Based Approach for Mitigating Societal Bias in Chronic Kidney Disease Data

    Article • Medical Decision Making, April 2026, SAGE Publications

    Dr Fernando Alarid-Escudero

  6. PRE-CISE: A PRE-calibration Coverage, Identifiability, and SEnsitivity analysis workflow to streamline model calibration

    Article • March 2026, openRxiv

    Dr Fernando Alarid-Escudero

  7. A Novel Decision-Modeling Framework for Health Policy Analyses When Outcomes Are Influenced by Social and Disease Processes

    Article • Medical Decision Making, February 2026, SAGE Publications

    Dr Fernando Alarid-Escudero

  8. Differences in Bladder Cancer Diagnosis by Demographic Factors: A Simulation Modeling Analysis

    Article • February 2026, openRxiv

    Dr Fernando Alarid-Escudero

  9. The best screening test is the one that gets followed up on

    Article • Gastroenterology, February 2026, Elsevier

    Dr Fernando Alarid-Escudero

  10. Discrete-Event Simulation Modeling Framework for Cancer Interventions and Population Health in R (DESCIPHR): An Open-Source Pipeline

    Article • PharmacoEconomics, January 2026, Springer Science + Business Media

    Dr Fernando Alarid-Escudero

  11. Bladder Cancer Burden in the USA: Population Scenarios for 2040

    Article • European Urology Open Science, January 2026, Elsevier

    Dr Fernando Alarid-Escudero

  12. The cost of non-drug interventions that improve function and reduce dementia-related behaviors

    Article • BMC Geriatrics, December 2025, Springer Science + Business Media

    Dr Fernando Alarid-Escudero

  13. Public-health impact of increasing human papillomavirus vaccination and cervical cancer screening

    Article • JNCI Journal of the National Cancer Institute, October 2025, Oxford University Press (OUP)

    Dr Fernando Alarid-Escudero

  14. Reply to: Comment on Human Epidermal Growth Factor Receptor 2–Low Metastatic Breast Cancer Treatment Costs and Cost-Effectiveness

    Article • Journal of Clinical Oncology, September 2025, American Society of Clinical Oncology (ASCO)

    Dr Fernando Alarid-Escudero

  15. Data from Long-term Trends in Bladder Cancer Incidence Using a Harmonized Staging Variable: A SEER-Based Study

    Article • September 2025, American Association for Cancer Research (AACR)

    Dr Fernando Alarid-Escudero

  16. Supplementary Figure S1 from Long-term Trends in Bladder Cancer Incidence Using a Harmonized Staging Variable: A SEER-Based Study

    Article • September 2025, American Association for Cancer Research (AACR)

    Dr Fernando Alarid-Escudero

  17. Supplementary Figure S2 from Long-term Trends in Bladder Cancer Incidence Using a Harmonized Staging Variable: A SEER-Based Study

    Article • September 2025, American Association for Cancer Research (AACR)

    Dr Fernando Alarid-Escudero

  18. Supplementary Table S1 from Long-term Trends in Bladder Cancer Incidence Using a Harmonized Staging Variable: A SEER-Based Study

    Article • September 2025, American Association for Cancer Research (AACR)

    Dr Fernando Alarid-Escudero

  19. Long-term trends in bladder cancer incidence using a harmonized staging variable – A SEER-based study

    Article • Cancer Epidemiology Biomarkers & Prevention, July 2025, American Association for Cancer Research (AACR)

    Dr Fernando Alarid-Escudero

  20. Benefits of colorectal cancer screening using FIT with varying positivity thresholds by age and sex

    Article • JNCI Journal of the National Cancer Institute, June 2025, Oxford University Press (OUP)

    Dr Fernando Alarid-Escudero

  21. Cost and Cost-Effectiveness of Treating Human Epidermal Growth Factor Receptor 2–Low Metastatic Breast Cancer

    Article • Journal of Clinical Oncology, May 2025, American Society of Clinical Oncology (ASCO)

    Dr Fernando Alarid-Escudero

  22. A Tutorial on Discrete Event Simulation Models in R Using a Cost-Effectiveness Analysis Example

    Article • May 2025, Cold Spring Harbor Laboratory Press

    Dr Fernando Alarid-Escudero

  23. Discrete-Event Simulation Model for Cancer Interventions and Population Health in R (DESCIPHR): An Open-Source Pipeline

    Article • May 2025, Cold Spring Harbor Laboratory Press

    Dr Fernando Alarid-Escudero

  24. Calculating epidemiological outcomes from simulated longitudinal data

    Article • May 2025, Cold Spring Harbor Laboratory Press

    Dr Fernando Alarid-Escudero

  25. Cost-Effectiveness of Using Conditional Economic Incentives to Improve Pre-exposure Prophylaxis Adherence Among Male Sex Workers

    Article • PharmacoEconomics - Open, April 2025, Springer Science + Business Media

    Dr Fernando Alarid-Escudero

  26. A microsimulation-based framework for mitigating societal bias in primary care data

    Article • April 2025, Cold Spring Harbor Laboratory Press

    Dr Fernando Alarid-Escudero

  27. Cost-effectiveness of enfortumab vedotin and pembrolizumab for first-line metastatic urothelial cancer in the United States

    Article • Value in Health, April 2025, Elsevier

    Dr Fernando Alarid-Escudero

  28. Utility Values of Health Status in Gastric Cancer: A Systematic Review

    Article • Value in Health Regional Issues, March 2025, Elsevier

    Dr Fernando Alarid-Escudero

  29. A novel decision modeling framework for health policy analyses when outcomes are influenced by social and disease processes

    Article • February 2025, Cold Spring Harbor Laboratory Press

    Dr Fernando Alarid-Escudero

  30. A Fast Nonparametric Sampling Method for Time to Event in Individual-Level Simulation Models

    Article • Medical Decision Making, January 2025, SAGE Publications

    Dr Fernando Alarid-Escudero

  31. Microsimulation Estimates of Decision Uncertainty and Value of Information Are Biased but Consistent

    Article • Medical Decision Making, December 2024, SAGE Publications

    Dr Fernando Alarid-Escudero

  32. State-level disparities in cervical cancer prevention and outcomes in the U.S.: a modeling study

    Article • JNCI Journal of the National Cancer Institute, November 2024, Oxford University Press (OUP)

    Dr Fernando Alarid-Escudero

  33. Primary HPV screening compared with other cervical cancer screening strategies in women with HIV: a cost-effectiveness study

    Article • AIDS, September 2024, Wolters Kluwer Health

    Dr Fernando Alarid-Escudero

  34. Helicobacter pylori infection in the United States beyond NHANES: a scoping review of seroprevalence estimates by racial and ethnic groups

    Article • The Lancet Regional Health - Americas, September 2024, Elsevier

    Dr Fernando Alarid-Escudero

  35. Birth cohort and age-specific trends in global Helicobacter pylori seroprevalence: a scoping review

    Article • The Lancet Regional Health - Americas, August 2024, Elsevier

    Dr Fernando Alarid-Escudero

  36. Incentivizing adherence to pre-exposure prophylaxis for HIV prevention: a randomized pilot trial among male sex workers in Mexico

    Article • The European Journal of Health Economics, July 2024, Springer Science + Business Media

    Dr Fernando Alarid-Escudero

  37. Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With a Blood Test That Meets the Centers for Medicare & Medicaid Services Coverage Decision

    Article • Gastroenterology, July 2024, Elsevier

    Dr Fernando Alarid-Escudero

  38. State-level disparities in cervical cancer prevention and impact on outcomes in the U.S.: A modeling study

    Article • June 2024, Cold Spring Harbor Laboratory Press

    Dr Fernando Alarid-Escudero

  39. Emulator-Based Bayesian Calibration of the CISNET Colorectal Cancer Models

    Article • Medical Decision Making, June 2024, SAGE Publications

    Dr Fernando Alarid-Escudero

  40. Characteristics of a cost-effective blood test for colorectal cancer screening

    Article • JNCI Journal of the National Cancer Institute, June 2024, Oxford University Press (OUP)

    Dr Fernando Alarid-Escudero

  41. A Fast Nonparametric Sampling (NPS) Method for Time-to-Event in Individual-Level Simulation Models.

    Article • April 2024, Cold Spring Harbor Laboratory Press

    Dr Fernando Alarid-Escudero

  42. Using Age-Specific Rates for Parametric Survival Function Estimation in Simulation Models

    Article • Medical Decision Making, February 2024, SAGE Publications

    Dr Fernando Alarid-Escudero, Javier Mar

  43. Value of Information: Success Stories

    Article • December 2023, Taylor & Francis

    Dr Fernando Alarid-Escudero

  44. Effects of Mitigation and Control Policies in Realistic Epidemic Models Accounting for Household Transmission Dynamics

    Article • Medical Decision Making, November 2023, SAGE Publications

    Dr Fernando Alarid-Escudero

  45. Approaches to developing de novo cancer population models to examine questions about cancer and race in bladder, gastric, and endometrial cancer and multiple myeloma: the Cancer Intervention and Surveillance Modeling Network incubator program

    Article • JNCI Monographs, November 2023, Oxford University Press (OUP)

    Dr Fernando Alarid-Escudero

  46. NordICC Trial Results in Line With Expected Colorectal Cancer Mortality Reduction After Colonoscopy: A Modeling Study

    Article • Gastroenterology, October 2023, Elsevier

    Dr Fernando Alarid-Escudero

  47. Cost-effectiveness of trastuzumab deruxtecan in HER2 low metastatic breast cancer.

    Article • Journal of Clinical Oncology, June 2023, American Society of Clinical Oncology (ASCO)

    Dr Fernando Alarid-Escudero

  48. Breastfeeding is associated with the intelligence of school‐age children in Mexico

    Article • Maternal and Child Nutrition, May 2023, Wiley

    Dr Fernando Alarid-Escudero

  49. Cost effectiveness of non‐drug interventions that reduce nursing home admissions for people living with dementia

    Article • Alzheimer s & Dementia, April 2023, Wiley

    Dr Fernando Alarid-Escudero

  50. Emulator-based Bayesian calibration of the CISNET colorectal cancer models

    Article • March 2023, Cold Spring Harbor Laboratory Press

    Dr Fernando Alarid-Escudero

  51. Effects of Mitigation and Control Policies in Realistic Epidemic Models Accounting for Household Transmission Dynamics

    Article • January 2023, Cold Spring Harbor Laboratory Press

    Dr Fernando Alarid-Escudero, Prof. Sarman Singh

  52. A Tutorial on Time-Dependent Cohort State-Transition Models in R Using a Cost-Effectiveness Analysis Example

    Article • Medical Decision Making, September 2022, SAGE Publications

    Dr Fernando Alarid-Escudero

  53. Dynamics of Respiratory Infectious Diseases in Incarcerated and Free-Living Populations: A Simulation Modeling Study

    Article • Medical Decision Making, July 2022, SAGE Publications

    Dr Fernando Alarid-Escudero

  54. An Introductory Tutorial on Cohort State-Transition Models in R Using a Cost-Effectiveness Analysis Example

    Article • Medical Decision Making, June 2022, SAGE Publications

    Dr Fernando Alarid-Escudero

  55. Methods for Communicating the Impact of Parameter Uncertainty in a Multiple-Strategies Cost-Effectiveness Comparison

    Article • Medical Decision Making, May 2022, SAGE Publications

    Dr Fernando Alarid-Escudero

  56. Characterization and Valuation of the Uncertainty of Calibrated Parameters in Microsimulation Decision Models

    Article • Frontiers in Physiology, May 2022, Frontiers

    Dr Fernando Alarid-Escudero

  57. CDX2 Biomarker Testing and Adjuvant Therapy for Stage II Colon Cancer: An Exploratory Cost-Effectiveness Analysis

    Article • Value in Health, March 2022, Elsevier

    Dr Fernando Alarid-Escudero

  58. Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Among Incarcerated People in California State Prisons: Retrospective Cohort Study

    Article • Clinical Infectious Diseases, January 2022, Oxford University Press (OUP)

    Dr Fernando Alarid-Escudero

  59. Retention in Care, Mortality, Loss-to-Follow-Up, and Viral Suppression among Antiretroviral Treatment-Naïve and Experienced Persons Participating in a Nationally Representative HIV Pre-Treatment Drug Resistance Survey in Mexico

    Article • Pathogens, December 2021, MDPI AG

    Dr Fernando Alarid-Escudero

  60. Age-specific rates of onset of cannabis use in Mexico

    Article • Addictive Behaviors, November 2021, Elsevier

    Dr Fernando Alarid-Escudero

  61. Outbreaks of COVID-19 variants in US prisons: a mathematical modelling analysis of vaccination and reopening policies

    Article • The Lancet Public Health, October 2021, Elsevier

    Dr Fernando Alarid-Escudero

  62. Effectiveness of COVID-19 Vaccines among Incarcerated People in California State Prisons: A Retrospective Cohort Study

    Article • August 2021, Cold Spring Harbor Laboratory Press

    Dr Fernando Alarid-Escudero

  63. COVID-19 in the California State Prison System: an Observational Study of Decarceration, Ongoing Risks, and Risk Factors

    Article • Journal of General Internal Medicine, July 2021, Springer Science + Business Media

    Dr Fernando Alarid-Escudero

  64. Dependence of COVID-19 Policies on End-of-Year Holiday Contacts in Mexico City Metropolitan Area: A Modeling Study

    Article • MDM Policy & Practice, July 2021, SAGE Publications

    Dr Fernando Alarid-Escudero

  65. Prioritizing Research Informing Antibiotic Prophylaxis Guidelines for Knee Arthroplasty Patients

    Article • JDR Clinical & Translational Research, June 2021, SAGE Publications

    Dr Fernando Alarid-Escudero

  66. BayCANN: Streamlining Bayesian Calibration With Artificial Neural Network Metamodeling

    Article • Frontiers in Physiology, May 2021, Frontiers

    Dr Fernando Alarid-Escudero

  67. Covid-19 Vaccine Acceptance in California State Prisons

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, May 2021, New England Journal of Medicine (NEJM/MMS)

    Dr Fernando Alarid-Escudero

  68. Outbreaks of Covid-19 Variants in Prisons: A Mathematical Modeling Analysis of Vaccination and Re-Opening Policies

    Article • May 2021, Cold Spring Harbor Laboratory Press

    Dr Fernando Alarid-Escudero

  69. Covid-19 in the California State Prison System: An Observational Study of Decarceration, Ongoing Risks, and Risk Factors

    Article • March 2021, Cold Spring Harbor Laboratory Press

    Dr Fernando Alarid-Escudero

  70. Cost-effectiveness of prevention and early detection of gastric cancer in Western countries

    Article • Best Practice & Research Clinical Gastroenterology, March 2021, Elsevier

    Dr Fernando Alarid-Escudero

  71. How do Covid-19 policy options depend on end-of-year holiday contacts in Mexico City Metropolitan Area? A Modeling Study

    Article • December 2020, Cold Spring Harbor Laboratory Press

    Dr Fernando Alarid-Escudero

  72. Age-Specific Rates of Onset of Cannabis Use in Mexico

    Article • December 2020, Cold Spring Harbor Laboratory Press

    Dr Fernando Alarid-Escudero

  73. The Household Secondary Attack Rate of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Rapid Review

    Article • Clinical Infectious Diseases, October 2020, Oxford University Press (OUP)

    Dr Fernando Alarid-Escudero

  74. A Summary of the 2020 Gastric Cancer Summit at Stanford University

    Article • Gastroenterology, October 2020, Elsevier

    Dr Fernando Alarid-Escudero

  75. Estimating population-based recurrence rates of colorectal cancer over time in the United States

    Article • Cancer Epidemiology Biomarkers & Prevention, September 2020, American Association for Cancer Research (AACR)

    Dr Fernando Alarid-Escudero

  76. Cost-effectiveness analysis of a multidisciplinary health-care model for patients with type-2 diabetes implemented in the public sector in Mexico: A quasi-experimental, retrospective evaluation

    Article • Diabetes Research and Clinical Practice, September 2020, Elsevier

    Dr Fernando Alarid-Escudero

  77. Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening Tests

    Article • JNCI Journal of the National Cancer Institute, August 2020, Oxford University Press (OUP)

    Dr Fernando Alarid-Escudero

  78. Validation of Microsimulation Models Used for Population Health Policy

    Article • July 2020, Oxford University Press (OUP)

    Dr Fernando Alarid-Escudero

  79. Discussing Cervical Cancer Screening Options: Outcomes to Guide Conversations Between Patients and Providers

    Article • MDM Policy & Practice, July 2020, SAGE Publications

    Dr Fernando Alarid-Escudero

  80. Computing the Expected Value of Sample Information Efficiently: Practical Guidance and Recommendations for Four Model-Based Methods

    Article • Value in Health, June 2020, Elsevier

    Dr Fernando Alarid-Escudero

  81. Calculating the Expected Value of Sample Information in Practice: Considerations from 3 Case Studies

    Article • Medical Decision Making, April 2020, SAGE Publications

    Dr Fernando Alarid-Escudero

  82. A Multidimensional Array Representation of State-Transition Model Dynamics

    Article • Medical Decision Making, January 2020, SAGE Publications

    Dr Fernando Alarid-Escudero

  83. Estimating the Natural History of Cervical Carcinogenesis Using Simulation Models: A CISNET Comparative Analysis

    Article • JNCI Journal of the National Cancer Institute, December 2019, Oxford University Press (OUP)

    Dr Fernando Alarid-Escudero

  84. Potential Bias Associated with Modeling the Effectiveness of Healthcare Interventions in Reducing Mortality Using an Overall Hazard Ratio

    Article • PharmacoEconomics, November 2019, Springer Science + Business Media

    Dr Fernando Alarid-Escudero

  85. Midwife‐led care and obstetrician‐led care for low‐risk pregnancies: A cost comparison

    Article • Birth, November 2019, Wiley

    Dr Fernando Alarid-Escudero

  86. A Cost-effectiveness Analysis of Systemic Therapy for Metastatic Hormone-sensitive Prostate Cancer

    Article • European Urology Oncology, November 2019, Elsevier

    Dr Fernando Alarid-Escudero, Professor Nathan Lawrentschuk

  87. A Value of Information Analysis of Research on the 21-Gene Assay for Breast Cancer Management

    Article • Value in Health, October 2019, Elsevier

    Dr Fernando Alarid-Escudero

  88. A Need for Change! A Coding Framework for Improving Transparency in Decision Modeling

    Article • PharmacoEconomics, September 2019, Springer Science + Business Media

    Dr Fernando Alarid-Escudero

  89. A Multidimensional Array Representation of State-Transition Model Dynamics

    Article • June 2019, Cold Spring Harbor Laboratory Press

    Dr Fernando Alarid-Escudero

  90. Estimated Quality of Life and Economic Outcomes Associated With 12 Cervical Cancer Screening Strategies

    Article • JAMA Internal Medicine, May 2019, American Medical Association (AMA)

    Dr Fernando Alarid-Escudero

  91. “Time Traveling Is Just Too Dangerous” but Some Methods Are Worth Revisiting: The Advantages of Expected Loss Curves Over Cost-Effectiveness Acceptability Curves and Frontier

    Article • Value in Health, May 2019, Elsevier

    Dr Fernando Alarid-Escudero

  92. The Curve of Optimal Sample Size (COSS): A Graphical Representation of the Optimal Sample Size from a Value of Information Analysis

    Article • PharmacoEconomics, February 2019, Springer Science + Business Media

    Dr Fernando Alarid-Escudero

  93. Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer

    Article • European Urology, November 2018, Elsevier

    Dr Fernando Alarid-Escudero, Professor Nathan Lawrentschuk

  94. Nonidentifiability in model calibration and its implications for medical decision making.

    Article • Medical Decision Making, September 2018, SAGE Publications

    Dr Fernando Alarid-Escudero

  95. Revisiting assumptions about age-based sexual mixing representations in mathematical models

    Article • Vaccine, September 2018, Elsevier

    Dr Fernando Alarid-Escudero

  96. Incorporating Biomarkers into the Primary Prostate Biopsy Setting: A Cost-Effectiveness Analysis

    Article • The Journal of Urology, June 2018, Elsevier

    Dr Fernando Alarid-Escudero, Professor Nathan Lawrentschuk

  97. Force of infection of Helicobacter pylori in Mexico: evidence from a national survey using a hierarchical Bayesian model – CORRIGENDUM

    Article • Epidemiology and Infection, June 2018, Cambridge University Press

    Dr Fernando Alarid-Escudero

  98. Force of infection of Helicobacter pylori in Mexico: evidence from a national survey using a hierarchical Bayesian model

    Article • Epidemiology and Infection, April 2018, Cambridge University Press

    Dr Fernando Alarid-Escudero

  99. Microsimulation modeling in R: A tutorial

    Article • Medical Decision Making, March 2018, SAGE Publications

    Dr Fernando Alarid-Escudero

  100. A Kinked Health Insurance Market: Employer-Sponsored Insurance under the Cadillac Tax

    Article • American Journal of Health Economics, August 2017, The MIT Press

    Dr Fernando Alarid-Escudero

  101. A Gaussian Approximation to efficiently compute the expected value of sample information (EVSI)

    Article • Medical Decision Making, July 2017, SAGE Publications

    Hawre Jalal, Dr Fernando Alarid-Escudero

  102. Prioritizing Future Research on Allopurinol and Febuxostat for the Management of Gout: Value of Information Analysis

    Article • PharmacoEconomics, June 2017, Springer Science + Business Media

    Dr Fernando Alarid-Escudero

  103. Trade-offs Between Efficacy and Cardiac Toxicity of Adjuvant Chemotherapy in Early-Stage Breast Cancer Patients: Do Competing Risks Matter?

    Article • January 2017, Wiley

    Dr Fernando Alarid-Escudero

  104. An Overview of R in Health Decision Sciences

    Article • Medical Decision Making, January 2017, SAGE Publications

    Hawre Jalal, Dr Fernando Alarid-Escudero

  105. Modeling the Cost-Effectiveness of Doula Care Associated with Reductions in Preterm Birth and Cesarean Delivery

    Article • January 2016, Wiley

    Dr Fernando Alarid-Escudero

  106. Análisis de costo-beneficio: prevención del VIH/sida en migrantes en Centroamérica

    Article • Salud Pública de México, January 2013, Instituto Nacional de Salud Publica

    Dr Fernando Alarid-Escudero

  107. Registro de señales de EEG para aplicaciones de Interfaz Cerebro Computadora (ICC) basado en Potenciales Evocados Visuales de Estado Estacionario (PEVEE)

    Article • January 2007, Springer Science + Business Media

    Dr Fernando Alarid-Escudero